Cita APA

Wilkin, T. J., Su, Z., Krambrink, A., Long, J., Greaves, W., Gross, R., . . . Gulick, R. M. (2010). Three-Year Safety and Efficacy of Vicriviroc, a CCR5 Antagonist, in HIV-1-Infected, Treatment-Experienced Patients.

Citación estilo Chicago

Wilkin, Timothy J., et al. Three-Year Safety and Efficacy of Vicriviroc, a CCR5 Antagonist, in HIV-1-Infected, Treatment-Experienced Patients. 2010.

Cita MLA

Wilkin, Timothy J., et al. Three-Year Safety and Efficacy of Vicriviroc, a CCR5 Antagonist, in HIV-1-Infected, Treatment-Experienced Patients. 2010.